Viking Therapeutics Inc
General ticker "VKTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.4B
Viking Therapeutics Inc follows the US Stock Market performance with the rate: 26.1%.
Estimated limits based on current volatility of 4.4%: low 40.05$, high 43.75$
Factors to consider:
- Current price 98.6% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [11.31$, 21.31$]
- 2024-12-30 to 2025-12-30 estimated range: [8.54$, 17.15$]
Financial Metrics affecting the VKTX estimates:
- Negative: Non-GAAP EPS, $ of -0.92 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -4.43 <= 2.35
- Negative: negative Net income
- Positive: -3.48 < Investing cash flow per share, $ of -1.90
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0.14
Short-term VKTX quotes
Long-term VKTX plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $55.68MM | $70.36MM | $100.83MM |
Operating Income | $-55.68MM | $-70.36MM | $-100.83MM |
Non-Operating Income | $1.38MM | $2.72MM | $14.93MM |
Interest Expense | $0.02MM | $0.00MM | $0.09MM |
R&D Expense | $44.98MM | $54.23MM | $63.81MM |
Income(Loss) | $-54.30MM | $-67.64MM | $-85.89MM |
Profit(Loss) | $-54.30MM | $-67.64MM | $-85.89MM |
Stockholders Equity | $201.88MM | $145.32MM | $348.42MM |
Assets | $210.66MM | $168.53MM | $368.49MM |
Operating Cash Flow | $-47.59MM | $-48.40MM | $-73.38MM |
Investing Cash Flow | $37.96MM | $54.75MM | $-179.09MM |
Financing Cash Flow | $6.88MM | $4.16MM | $271.38MM |
Earnings Per Share* | $-0.70 | $-0.88 | $-0.91 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.